- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Diagnostyka SA (DIAP)
Diagnostyka SA stock price live, this page displays WA DIAP stock exchange data. View the DIAP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Diagnostyka SA real time stock price chart below.
What Is the Diagnostyka SA Stock Price Today?
The Diagnostyka SA stock price today is 161.10.
What Is the Stock Symbol for Diagnostyka SA?
The stock symbol for Diagnostyka SA is "DIAP."
What Stock Exchange Does Diagnostyka SA Trade On?
Diagnostyka SA is listed and trades on the Warsaw stock exchange.
Is Diagnostyka SA a Good Stock to Buy?
Determining whether Diagnostyka SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DIAP quote. (ISIN: PLDGNST00012)
What Is the Diagnostyka SA Stock Price Today?
The Diagnostyka SA stock price today is 161.10.
What Is the Stock Symbol for Diagnostyka SA?
The stock symbol for Diagnostyka SA is "DIAP."
What Stock Exchange Does Diagnostyka SA Trade On?
Diagnostyka SA is listed and trades on the Warsaw stock exchange.
Is Diagnostyka SA a Good Stock to Buy?
Determining whether Diagnostyka SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DIAP quote. (ISIN: PLDGNST00012)
161.10
-0.10(-0.06%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
160.10
162.50
52 wk Range
146.40
219.90
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
160.10162.50
52 wk Range
146.40219.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.73%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DIAP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
210.45
Upside
+30.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
- Diagnostyka receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Diagnostyka receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 210.45
(+30.63% Upside)
Earnings
Latest Release
Apr 20, 2026
EPS / Forecast
1.09 / --
Revenue / Forecast
619.6M / --
Compare DIAP to Peers and Sector
Metrics to compare | DIAP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDIAPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.5x | 18.5x | −0.5x | |
PEG Ratio | 1.72 | 0.32 | 0.00 | |
Price/Book | 10.2x | 3.2x | 2.6x | |
Price / LTM Sales | 2.2x | 1.9x | 3.1x | |
Upside (Analyst Target) | 31.7% | 22.0% | 53.0% | |
Fair Value Upside | Unlock | 11.1% | 6.3% | Unlock |
Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Diagnostyka (DIAP) Stock Price Today?
The Diagnostyka stock price today is 161.10 PLN.
What Stock Exchange Does Diagnostyka Trade On?
Diagnostyka is listed and trades on the Warsaw Stock Exchange.
What Is the Stock Symbol for Diagnostyka?
The stock symbol for Diagnostyka is "DIAP."
Does Diagnostyka Pay Dividends? What’s The Current Dividend Yield?
The Diagnostyka dividend yield is 2.73%.
What Is the Diagnostyka Market Cap?
As of today, Diagnostyka market cap is 5.44B PLN.
What Is Diagnostyka's Earnings Per Share (TTM)?
The Diagnostyka EPS (TTM) is 7.45.
When Is the Next Diagnostyka Earnings Date?
Diagnostyka will release its next earnings report on May 28, 2026.
From a Technical Analysis Perspective, Is DIAP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Diagnostyka Stock Split?
Diagnostyka has split 0 times.
How Many Employees Does Diagnostyka Have?
Diagnostyka has 8645 employees.
What is the current trading status of Diagnostyka (DIAP)?
As of May 22, 2026, Diagnostyka (DIAP) is trading at a price of 161.10 PLN, with a previous close of 161.20 PLN. The stock has fluctuated within a day range of 160.10 PLN to 162.50 PLN, while its 52-week range spans from 146.40 PLN to 219.90 PLN.
What Is Diagnostyka (DIAP) Price Target According to Analysts?
The average 12-month price target for Diagnostyka is 210.45 PLN, with a high estimate of 230 PLN and a low estimate of 188 PLN. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +30.63% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.